Astria Therapeutics, Inc. (ATXS)
12.96
-0.04
(-0.35%)
USD |
NASDAQ |
Dec 09, 16:00
12.96
0.00 (0.00%)
After-Hours: 18:02
Astria Therapeutics EPS Diluted (Quarterly): -0.5455 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 0.0587 |
| Hologic, Inc. | 0.8298 |
| Johnson & Johnson | 2.121 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.64M |
| Revenue (Quarterly) | 0.706M |
| Total Expenses (Quarterly) | 32.35M |
| Enterprise Value | 614.16M |
| Profit Margin (Quarterly) | -4.48K% |
| Earnings Yield | -16.60% |
| Normalized Earnings Yield | -16.60 |